Status:
COMPLETED
Clinical Value of Metagenomic Sequencing in Neonatal Sepsis
Lead Sponsor:
Children's Hospital of Fudan University
Collaborating Sponsors:
Quanzhou Women's and Children's Hospital
Shengjing Hospital
Conditions:
Neonatal Sepsis
Eligibility:
All Genders
Up to 28 years
Brief Summary
This study aimed to enroll 2000 neonatal patients with suspected sepsis or clinical diagnosed sepsis. These patients will undergo both conventional methods and metagenomics sequencing to detect the pa...
Detailed Description
Infectious diseases remain leading causes of mortality and morbidity in children. Rapid and accurate diagnosis of infectious diseases in children is important for developing an effective treatment and...
Eligibility Criteria
Inclusion
- Neonates with suspected early-onset sepsis or late-onset sepsis;
- Neonates diagnosed with clinical sepsis.
Exclusion
- Died before the results of conventional methods test or metagenomics test were obtained;
- Suffering from diseases of the blood system;
- Suffering from malignant tumor;
- Birth defects, congenital heart disease or autoimmune disease.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05416918
Start Date
April 1 2022
End Date
December 30 2022
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children Hospital of Fudan University
Shanghai, China, 201102